We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+3.21%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$31.1B
AUM Growth
Cap. Flow
+$31.1B
Cap. Flow %
99.86%
Top 10 Hldgs %
15.32%
Holding
3,313
New
3,312
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$747M
2
XOM icon
ExxonMobil
XOM
+$735M
3
MSFT icon
Microsoft
MSFT
+$507M
4
CVX icon
Chevron
CVX
+$429M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$427M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Financials 15.07%
2 Technology 13.69%
3 Healthcare 12.3%
4 Industrials 10.73%
5 Consumer Staples 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COB
2901
DELISTED
CommunityOne Bancorp
COB
$117K ﹤0.01%
+14,454
New +$116K
INTX
2902
DELISTED
Intersections, Inc.
INTX
$116K ﹤0.01%
+13,183
New +$124K
NEO icon
2903
NeoGenomics
NEO
$2.04B
$115K ﹤0.01%
+28,800
New +$110K
GLUU
2904
DELISTED
Glu Mobile Inc.
GLUU
$113K ﹤0.01%
+51,310
New +$138K
MITK icon
2905
Mitek Systems
MITK
$771M
$112K ﹤0.01%
+19,360
New +$104K
EGAN icon
2906
eGain
EGAN
$183M
$111K ﹤0.01%
+11,510
New +$93.9K
PZN
2907
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$110K ﹤0.01%
+16,896
New +$107K
IMI
2908
DELISTED
Intermolecular, Inc.
IMI
$110K ﹤0.01%
+15,158
New +$129K
ENPH icon
2909
Enphase Energy
ENPH
$4.94B
$109K ﹤0.01%
+14,094
New +$99.8K
BREW
2910
DELISTED
Craft Brew Alliance, Inc.
BREW
$108K ﹤0.01%
+13,094
New +$100K
CYNI
2911
DELISTED
CYAN INC COM
CYNI
$108K ﹤0.01%
+10,360
New +$125K
DWSN icon
2912
Dawson Geophysical
DWSN
$143M
$107K ﹤0.01%
+4,542
New +$113K
RVLT
2913
DELISTED
Revolution Lighting Technologies, Inc. - Class A
RVLT
$107K ﹤0.01%
+2,685
New +$87.2K
ZGNX
2914
DELISTED
Zogenix, Inc.
ZGNX
$107K ﹤0.01%
+7,840
New +$100K
BDSI
2915
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$107K ﹤0.01%
+26,249
New +$123K
LCTX icon
2916
Lineage Cell Therapeutics
LCTX
$277M
$105K ﹤0.01%
+32,742
New +$105K
BIOL
2917
DELISTED
Biolase, Inc.
BIOL
$105K ﹤0.01%
+2
New +$112K
SALM
2918
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$104K ﹤0.01%
+13,871
New +$113K
SNAK
2919
DELISTED
Inventure Foods, Inc.
SNAK
$104K ﹤0.01%
+12,420
New +$94.4K
CTIC
2920
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$104K ﹤0.01%
+9,951
New +$117K
CEMP
2921
DELISTED
Cempra, Inc.
CEMP
$102K ﹤0.01%
+13,016
New +$89.9K
MSO
2922
DELISTED
MARTHA STEWART LIVING OMNIMEDIA INC
MSO
$102K ﹤0.01%
+42,117
New +$103K
ZLTQ
2923
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$98K ﹤0.01%
+15,269
New +$72.6K
MDW
2924
DELISTED
MIDWAY GOLD CORP (CANADA)
MDW
$98K ﹤0.01%
+103,574
New +$104K
CRTX
2925
DELISTED
CORNERSTONE THERAPEUTICS INC
CRTX
$97K ﹤0.01%
+12,142
New +$102K

Similar funds

RhumbLine Advisers's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for RhumbLine Advisers, which disclosed 3,313 positions worth $31.1B. Its ten largest holdings account for 15% of the portfolio.

Its largest position is Apple: 48,576,080 shares worth $687M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, followed by Technology and Healthcare.

  • RhumbLine Advisers's largest Q2 2013 buy was Apple: 48,576,080 shares worth $687M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $31.1B portfolio in Q2 2013.
  • RhumbLine Advisers disclosed 3,313 positions in Q2 2013, its first 13F filing on record.

Based on RhumbLine Advisers's 13F filing for Q2 2013, filed 7 Aug 2013.